Answers are grounded in this paper and cite their sources.
Theoretical framework reveals malignancy is linked to metabolic throughput collapse, suggesting targeted therapies often fail.
Traditional oncology operates under the assumption that cancer is a cumulative genetic error. However, this mutation-centric paradigm fails to explain phenotypic convergence, therapeutic resistance, and the statistical impossibility of tumor formation via stochastic events alone. This paper introduces the Tumor Probability Collapse Theorem (Micro-TNA), demonstrating a 70-order-of-magnitude discrepancy between mutational combinatorial space and observed oncogenesis. By applying the Theory of Axiomatic Necessity (TNA), we redefine late-stage cancer as a post-genetic thermodynamic regime. We show that malignancy is not driven by genetic novelty, but by the collapse of metabolic throughput (Psi) below a critical threshold (Psicrit). When a system can no longer export entropy (), it undergoes a phase transition from a specialized functional state (N^1) to a primitive, "functionally closed" survival state (N^0). This framework provides a quantitative basis for Medical Irreversibility, explaining why targeted therapies fail once the system enters a malignant attractor. We propose a shift from "fixing the code" to "engineering the flow," identifying the restoration of throughput as the primary requirement for system stability.
No takes yet. Share an insight, caveat, or question.
Claudio Bresciano (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: